-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Protagenic Therapeutics, Inc.\new quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2010 to Q3 2024.
- Protagenic Therapeutics, Inc.\new Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was -$2.52K.
- Protagenic Therapeutics, Inc.\new annual Income Tax Expense (Benefit) for 2016 was $0.000.
- Protagenic Therapeutics, Inc.\new annual Income Tax Expense (Benefit) for 2015 was $0.000.
- Protagenic Therapeutics, Inc.\new annual Income Tax Expense (Benefit) for 2014 was $0.000.
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Income Tax Expense (Benefit), Annual (USD)